ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Share Price Cross Above Fifty Day Moving Average – What’s Next?

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB)’s stock price crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $90.03 and traded as high as $99.53. ProShares Ultra Nasdaq Biotechnology shares last traded at $99.53, with a volume of 5,066 shares.

ProShares Ultra Nasdaq Biotechnology Trading Up 2.9%

The company has a market capitalization of $83.61 million, a P/E ratio of 20.68 and a beta of 1.19. The firm’s 50 day moving average price is $90.03 and its two-hundred day moving average price is $85.58.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the business. Franklin Resources Inc. bought a new position in ProShares Ultra Nasdaq Biotechnology in the second quarter valued at $32,000. Citadel Advisors LLC acquired a new stake in ProShares Ultra Nasdaq Biotechnology in the 3rd quarter valued at $307,000. Finally, Kaizen Financial Strategies bought a new stake in ProShares Ultra Nasdaq Biotechnology during the 4th quarter worth about $424,000.

ProShares Ultra Nasdaq Biotechnology Company Profile

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day.